One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial
- Hung Ling Huang
- , Meng Rui Lee
- , Chih Hsin Lee
- , Meng Hsuan Cheng
- , Po Liang Lu
- , Chau Chyun Sheu
- , Jann Yuan Wang
- , Inn Wen Chong
- , Jinn Moon Yang
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Citations
(Scopus)